InterLymph is a collaborative research consortium composed of investigators conducting epidemiologic studies of lymphoid malignancies. Membership supports international collaboration, pooled analyses, and shared scientific goals within an established governance framework.
Eligibility
Membership in InterLymph is open to investigators involved in epidemiologic, clinical, or methodological research related to lymphoid malignancies, including population‑based studies and collaborative research initiatives.
What Membership Involves
- Participation in collaborative scientific discussions
- Eligibility to contribute to working group activities
- Opportunity to take part in pooled or coordinated analyses
- Adherence to consortium policies on data use, authorship, and governance
How to Participate
Scientific activities within InterLymph are organized through working groups focused on specific disease subtypes, methods, exposures, or outcomes. Members are encouraged to participate in one or more working groups aligned with their expertise and research interests.
Expressions of interest in InterLymph membership are reviewed in accordance with consortium governance procedures. Participation in specific analyses or activities is subject to approval by relevant working groups and adherence to established data use and authorship policies.
If you have any questions about InterLymph regarding membership, please contact Aaron at [email protected].